Favié, Laurent M. A.
Peeters-Scholte, Cacha M. P. C. D.
Bakker, Anouk
Tjabbes, Huibert
Egberts, Toine C. G.
van Bel, Frank
Rademaker, Carin M. A.
Vis, Peter
Groenendaal, Floris
Article History
Received: 28 September 2018
Revised: 17 September 2019
Accepted: 19 September 2019
First Online: 2 October 2019
Competing interests
: C.M.P.C.D.P.-S., F.v.B., and F.G. are the inventors of 2-iminobiotin as a neuroprotective agent in neonates with hypoxic–ischemic encephalopathy. C.M.P.C.D.P.-S. and H.T. are shareholders and consultants of Neurophyxia BV. P.V. is employed at LAP&P Consultants BV. The other authors declare no competing interests.